156 related articles for article (PubMed ID: 11302656)
21. Measurement of glycoprotein IIb/IIIa blockade by flow cytometry with fluorescein isothiocyanate-conjugated crotavirin, a member of disintegrins.
Liu CZ; Hur BT; Huang TF
Thromb Haemost; 1996 Oct; 76(4):585-91. PubMed ID: 8903000
[TBL] [Abstract][Full Text] [Related]
22. Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.
Gold HK; Coller BS; Yasuda T; Saito T; Fallon JT; Guerrero JL; Leinbach RC; Ziskind AA; Collen D
Circulation; 1988 Mar; 77(3):670-7. PubMed ID: 3124974
[TBL] [Abstract][Full Text] [Related]
23. Lysis of plasminogen activator-resistant platelet-rich coronary artery thrombus with combined bolus injection of recombinant tissue-type plasminogen activator and antiplatelet GPIIb/IIIa antibody.
Yasuda T; Gold HK; Leinbach RC; Saito T; Guerrero JL; Jang IK; Holt R; Fallon JT; Collen D
J Am Coll Cardiol; 1990 Dec; 16(7):1728-35. PubMed ID: 2123910
[TBL] [Abstract][Full Text] [Related]
24. ME3277, a GPIIb/IIIa antagonist reduces cerebral infarction without enhancing intracranial hemorrhage in photothrombotic occlusion of rabbit middle cerebral artery.
Kawano KI; Fujishima K; Ikeda Y; Kondo K; Umemura K
J Cereb Blood Flow Metab; 2000 Jun; 20(6):988-97. PubMed ID: 10894182
[TBL] [Abstract][Full Text] [Related]
25. Multiple roles for platelet GPIIb/IIIa and alphavbeta3 integrins in tumor growth, angiogenesis, and metastasis.
Trikha M; Zhou Z; Timar J; Raso E; Kennel M; Emmell E; Nakada MT
Cancer Res; 2002 May; 62(10):2824-33. PubMed ID: 12019160
[TBL] [Abstract][Full Text] [Related]
26. Antithrombotic effects of FK419, a novel nonpeptide platelet GPIIb/IIIa antagonist, in a guinea pig photochemically induced middle cerebral artery thrombosis model: comparison with ozagrel and argatroban.
Moriguchi A; Aoki T; Mihara K; Tojo N; Matsuoka N; Mutoh S
J Pharmacol Exp Ther; 2004 Mar; 308(3):1094-101. PubMed ID: 14634048
[TBL] [Abstract][Full Text] [Related]
27. The nonpeptide glycoprotein IIb/IIIa platelet receptor antagonist SM-20302 reduces tissue plasminogen activator-induced intracerebral hemorrhage after thromboembolic stroke.
Lapchak PA; Araujo DM; Song D; Zivin JA
Stroke; 2002 Jan; 33(1):147-52. PubMed ID: 11779904
[TBL] [Abstract][Full Text] [Related]
28. Absence of potentiation with murine antiplatelet GPIIb/IIIa antibody of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in a canine venous thrombosis model.
Spriggs D; Gold HK; Hashimoto Y; Van Houtte E; Vermylen J; Collen D
Thromb Haemost; 1989 Feb; 61(1):93-6. PubMed ID: 2501892
[TBL] [Abstract][Full Text] [Related]
29. 7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli.
Taylor FB; Coller BS; Chang AC; Peer G; Jordan R; Engellener W; Esmon CT
Blood; 1997 Jun; 89(11):4078-84. PubMed ID: 9166848
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura.
Hansen RJ; Balthasar JP
J Pharmacol Exp Ther; 2001 Jul; 298(1):165-71. PubMed ID: 11408538
[TBL] [Abstract][Full Text] [Related]
31. Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets.
Wagner CL; Mascelli MA; Neblock DS; Weisman HF; Coller BS; Jordan RE
Blood; 1996 Aug; 88(3):907-14. PubMed ID: 8704248
[TBL] [Abstract][Full Text] [Related]
32. [Inhibition of thrombocyte aggregation by F(ab')2-fragments of monoclonal antibodies FraMon (CRC64) to glycoproteins IIb-IIIa].
Mazurov AV; Pevzner DV; Khaspekova SG; Dudnik OA; Byzova TV; Vlasik TN; Bakharev VN; Pistsov MIu; Staroverov II; Ruda MIa
Ter Arkh; 2001; 73(9):66-73. PubMed ID: 11642086
[TBL] [Abstract][Full Text] [Related]
33. Map-ISODATA demarcates regional response to combination rt-PA and 7E3 F(ab')2 treatment of embolic stroke in the rat.
Li L; Jiang Q; Ding G; Zhang L; Zhang ZG; Ewing JR; Knight RA; Kapke A; Soltanian-Zadeh H; Chopp M
J Magn Reson Imaging; 2005 Jun; 21(6):726-34. PubMed ID: 15906325
[TBL] [Abstract][Full Text] [Related]
34. A monoclonal antibody against the platelet glycoprotein IIb/IIIa receptor complex prevents platelet aggregation and thrombosis in a canine model of coronary angioplasty.
Bates ER; McGillem MJ; Mickelson JK; Pitt B; Mancini GB
Circulation; 1991 Dec; 84(6):2463-9. PubMed ID: 1659954
[TBL] [Abstract][Full Text] [Related]
35. Benefit of bolus-only platelet glycoprotein IIb/IIIa inhibition during percutaneous coronary intervention: insights from the very early outcomes in the Evaluation of 7E3 for the Prevention of Ischemic Complications (EPIC) trial.
Marmur JD; Mitre CA; Barnathan E; Cavusoglu E
Am Heart J; 2006 Nov; 152(5):876-81. PubMed ID: 17070148
[TBL] [Abstract][Full Text] [Related]
36. Integrin alpha(IIb)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia.
Abumiya T; Fitridge R; Mazur C; Copeland BR; Koziol JA; Tschopp JF; Pierschbacher MD; del Zoppo GJ
Stroke; 2000 Jun; 31(6):1402-09; discussion 1409-10. PubMed ID: 10835463
[TBL] [Abstract][Full Text] [Related]
37. Abolition of in vivo platelet thrombus formation in primates with monoclonal antibodies to the platelet GPIIb/IIIa receptor. Correlation with bleeding time, platelet aggregation, and blockade of GPIIb/IIIa receptors.
Coller BS; Folts JD; Smith SR; Scudder LE; Jordan R
Circulation; 1989 Dec; 80(6):1766-74. PubMed ID: 2598436
[TBL] [Abstract][Full Text] [Related]
38. Platelet GPIIb/IIIa receptor antagonists in human ischemic brain disease.
Seitz RJ; Siebler M
Curr Vasc Pharmacol; 2008 Jan; 6(1):29-36. PubMed ID: 18220937
[TBL] [Abstract][Full Text] [Related]
39. Postischemic treatment (2-4 h) with anti-CD11b and anti-CD18 monoclonal antibodies are neuroprotective after transient (2 h) focal cerebral ischemia in the rat.
Zhang ZG; Chopp M; Tang WX; Jiang N; Zhang RL
Brain Res; 1995 Nov; 698(1-2):79-85. PubMed ID: 8581506
[TBL] [Abstract][Full Text] [Related]
40. Reduced brain infarct volume and improved neurological outcome by inhibition of the NR2B subunit of NMDA receptors by using CP101,606-27 alone and in combination with rt-PA in a thromboembolic stroke model in rats.
Yang Y; Li Q; Yang T; Hussain M; Shuaib A
J Neurosurg; 2003 Feb; 98(2):397-403. PubMed ID: 12593629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
